Neubond Clinches Seed Funding to Advance Stroke Rehab Technology
Neubond, a London-based startup specializing in stroke rehabilitation technology, has announced the successful closure of a £1.5 million seed funding round. The financing was led by Waseda University Ventures, marking the venture capital firm's first investment in a UK-based company. Additional participation came from SFC Capital and New Wave Ventures.
Founders' Vision
Neubond was co-founded by Jumpei Kashiwakura and Patrick Sagastegui Alva. The company is developing a wearable device aimed at aiding stroke rehabilitation by providing sensory feedback to the brain, effectively simulating movement. This innovative technology is designed to enhance recovery outcomes for stroke patients by leveraging neuroplasticity.
Kashiwakura and Sagastegui Alva bring a wealth of experience to the table. "We are thrilled to have the support of such distinguished investors," said Kashiwakura. "This funding will accelerate our efforts to bring our rehabilitation solutions to those in need."
Investors and Strategic Importance
Waseda University Ventures' involvement as the lead investor is particularly noteworthy, as this marks their inaugural investment in a UK-based enterprise. Their participation underscores a growing interest in the intersection of healthtech and wearable technology. The additional backing from SFC Capital and New Wave Ventures further solidifies confidence in Neubond's potential.
Planned Use of Funds
The freshly acquired capital will be channeled into several key areas to facilitate Neubond's growth. The startup plans to expand its team, enhance product development, and focus on clinical trials to validate the efficacy of its technology. By doing so, Neubond aims to accelerate its path to market readiness and regulatory approval.
Looking Ahead
With the new funding, Neubond is poised to make significant strides in the field of stroke rehabilitation. The company is set to further its research and development efforts, aiming to provide a robust solution for improving the quality of life for stroke survivors. As they move forward, the focus will remain on innovation and expanding the reach of their technology to a broader patient population.
Neubond's funding announcement is a clear indicator of the promising developments in healthtech, particularly in the realm of wearable devices designed to aid rehabilitation and recovery.